Revvity Launches Signals AI to Advance Scientific R&D Workflows

Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D

Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?

RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay

Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution

RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution

Revvity, Inc. (RVTY) Q1 2026 Earnings Call Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity Announces Financial Results for the First Quarter of 2026

Revvity to Report Q1 Earnings: What's in Store for the Stock?

Revvity Board Declares Quarterly Dividend

Sumitomo Mitsui Trust Group Inc. Has $3.46 Million Stock Position in Revvity Inc. $RVTY

Revvity to Present at Upcoming Investor Conferences

RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data

Revvity to Hold Earnings Call on Tuesday, May 5, 2026

Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows

Revvity Gains on Diagnostics Strength, Faces China Headwinds

Allspring Global Investments Holdings LLC Raises Holdings in Revvity Inc. $RVTY

Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Why Is Revvity (RVTY) Down 5.1% Since Last Earnings Report?

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript

Revvity to Present at Upcoming Investor Conferences

Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

Revvity: Close To A Buy, Not Quite There

Here's Why Revvity (RVTY) is a Strong Momentum Stock

Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results

Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives

Revvity, Inc. (RVTY) Q4 2025 Earnings Call Transcript

Revvity's Strong Performance Overshadowed by Market Uncertainty

Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates

Revvity (RVTY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Revvity (RVTY) Q4 Earnings and Revenues Beat Estimates

Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2025

Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?

Curious about Revvity (RVTY) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Revvity Board Declares Quarterly Dividend

Revvity (RVTY) Earnings Expected to Grow: Should You Buy?

Universal Beteiligungs und Servicegesellschaft mbH Sells 24,911 Shares of Revvity Inc. $RVTY

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?

Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Campbell & CO Investment Adviser LLC Purchases New Holdings in Revvity Inc. $RVTY

Revvity, Inc. (RVTY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)